VDMN is an immunotherapy-containing dissolvable microarray being developed as an "injection-free" treatment for common warts WEST HARTFORD, Conn. , March 24, 2023 /PRNewswire-PRWeb/ -- Veradermics Inc ., a clinical-stage medical ...
SHANGHAI , March 13, 2023 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company") announced today that its partner Calliditas Therapeutics AB (Nasdaq: CALT, Nasdaq Stockholm: CALTX) ("Calliditas") reported positive ...
Multi-Site Phase 2A Study Evaluates Novel Gel For Subungual Application LAGUNA HILLS, Calif. , Feb. 28, 2023 /PRNewswire-PRWeb/ -- Hallux Inc., a specialty pharmaceutical company, today announced that it has exceeded its enrollment ...
SBS-1000 is the first arylepoxamide agonist for the treatment of pain to receive IND clearance. Phase 1 clinical trial will evaluate the safety, tolerability, pharmacokinetics, and analgesic efficacy of SBS-1000. SBS-1000 may present an ...
ROCKVILLE, Md. and SUZHOU, China , Feb. 15, 2023 /PRNewswire/ -- Innovent Biologics, Group. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for ...
Putting Australian clinical research on the map globally, comes the ground-breaking first-in-human clinical trial for KIO-301. MELBOURNE, Australia , Feb. 14, 2023 /PRNewswire/ -- In collaboration with US-based Kiora Pharmaceuticals, ...
OR AKIVA, Israel , Feb. 13, 2023 /PRNewswire/ -- EndoStream Medical today announced the first patient enrolled in the TORNADO-US clinical study in the U.S. This study evaluates the Nautilus™ Intrasaccular System, a revolutionary ...
SUZHOU, China , Feb. 10, 2023 /PRNewswire/ -- Kintor Pharmaceutical Limited ("Kintor Pharma", HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecules and biological therapeutics, announced the positive ...
VST-Bio's Collaborators Present Preclinical Trial Results at the American Heart Association International Stroke Conference in Dallas . SAN DIEGO , Feb. 10, 2023 /PRNewswire/ -- VST-Bio Corp. a leader in the development of ...
Egret Therapeutics, a portfolio company of Turret Capital Management, announces FDA Clearance of its IND Application for EGT 101 NEW YORK , Feb. 4, 2023 /PRNewswire/ -- Egret Therapeutics, a clinical-stage biotechnology company ...
Bharat Biotech, in collaboration with Biofabri, a Spanish biopharmaceutical firm, is conducting trials for the first live attenuated vaccine MTBVAC ( ) derived from a human strain of Mycobacterium tuberculosis. These trials aim to assess the safety and ...
A multisite clinical trial offers promising outcomes for patients with metastatic and recurrent uterine cancer, also known as endometrial cancer. Presented at the annual meeting of the Society of Gynecologic Oncologists, the study compiled data from ...
Researchers at the University of Oxford in the UK have initiated the first human clinical trial to evaluate ChAdOx1 NipahB vaccine designed to safeguard individuals against the deadly Nipah virus . ( ) ChAdOx1 NipahB Vaccine Trial with 51 Participants to Combat Nipah Virus Threat Fifty-one people aged 18 to 55 will participate in the ...
The stromal processing peptidase (SPP), a chloroplast plant enzyme, reduces the clumping of proteins that cause the pathogenic alterations in models of Huntingtons disease in human cells and the nematode Caenorhabditis elegans ( ). ...
A group of US researchers, who first conducted an ‘ artificial womb ’ experiment in lamb, are now seeking Food and Drug Administration (FDA) approval for its tests on humans ( ). This could potentially reduce deaths and disability for babies ...
Subscribe to our Free Newsletters!
Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment.
Full Disclaimer
Advertise with us | Medindia Copyright | Privacy Policy | Terms of Use © All Rights Reserved 1997 - 2024
Careers